The INGR1D2 study


What is INGR1D2 about?
INGR1D2 - INvestigating Genetic Risk for type 1 Diabetes (2) - is an important study that aims to identify children with genetic markers that put them at increased risk of developing type 1 diabetes.


Several maternity units in the East of England are offering parents the chance to involve their babies in this important study.

To date, over 36,000 babies in the UK have contributed this study which is looking at how we might prevent type 1 diabetes in the future.


East of England Sites

Who can take part in the study?

The INGR1D2 teams are currently approaching women at participating hospitals from Monday to Friday. If you are approached by one of our researchers, you will be given all the information you need to make a decision on whether to enrol your baby. We will approach any mothers over 18 weeks of pregnancy although the point at which you might be approached may vary between hospitals, and you may be approached after your baby has been born. If you have not yet been approached about the INGR1D2 study and would like to speak to a member of your local research team, please click here to find your local contact details.

The majority of babies will be able to take part in the study; there are only few exclusion criteria. If there is a specific reason that your baby cannot participate in the study, this will be explained to you in full.

To find out more

Please visit the study website: https://sites.google.com/nihr.ac.uk/ingr1d2/home?authuser=0